Cutler Group LP Intercept Pharmaceuticals, Inc. Transaction History

Cutler Group LP

$307 Million
Q1 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	SELL	$9.99 - $18.71 $999 - $1,871	-100 Reduced 0.56%	17,800 $330,000
Q1 2023 May 01, 2023	SELL	$12.53 - $21.71 $1,065 - $1,845	-85 Reduced 0.47%	17,900 $240,000
Q4 2022 Feb 07, 2023	SELL	$11.61 - $16.11 $25,669 - $35,619	-2,211 Reduced 10.95%	17,985 $222,000
Q3 2022 Oct 25, 2022	BUY	$12.21 - $19.7 $74,615 - $120,386	6,111 Added 43.39%	20,196 $281,000
Q2 2022 Aug 04, 2022	SELL	$11.23 - $19.59 $49,086 - $85,627	-4,371 Reduced 23.68%	14,085 $194,000
Q1 2022 Apr 14, 2022	BUY	$13.37 - $17.79 $137,122 - $182,454	10,256 Added 125.07%	18,456 $300,000
Q4 2021 Jan 18, 2022	SELL	$14.28 - $19.53 $15,708 - $21,483	-1,100 Reduced 11.83%	8,200 $133,000
Q3 2021 Oct 26, 2021	SELL	$12.99 - $20.47 $1,299 - $2,047	-100 Reduced 1.06%	9,300 $138,000
Q2 2021 Jul 19, 2021	SELL	$15.46 - $24.5 $6,184 - $9,800	-400 Reduced 4.08%	9,400 $187,000
Q1 2021 Apr 26, 2021	BUY	$19.33 - $37.75 $148,841 - $290,675	7,700 Added 366.67%	9,800 $226,000
Q4 2020 Jan 21, 2021	SELL	$24.48 - $42.47 $83,232 - $144,398	-3,400 Reduced 61.82%	2,100 $51,000
Q3 2020 Oct 27, 2020	BUY	$39.09 - $53.44 $121,179 - $165,664	3,100 Added 129.17%	5,500 $228,000
Q1 2020 May 07, 2020	BUY	$48.35 - $118.68 $38,680 - $94,944	800 Added 50.0%	2,400 $151,000
Q4 2019 Feb 06, 2020	BUY	$57.36 - $124.1 $72,273 - $156,366	1,260 Added 370.59%	1,600 $198,000
Q3 2019 Oct 28, 2019	SELL	$58.69 - $80.46 $26,997 - $37,011	-460 Reduced 57.5%	340 $22,000
Q2 2019 Aug 09, 2019	BUY	$77.77 - $120.68 $46,662 - $72,408	600 Added 300.0%	800 $63,000
Q1 2019 May 10, 2019	SELL	$91.83 - $120.68 $114,787 - $150,850	-1,250 Reduced 86.21%	200 $22,000
Q4 2018 Feb 05, 2019	SELL	$85.79 - $126.46 $46,326 - $68,288	-540 Reduced 27.14%	1,450 $146,000
Q2 2018 Aug 10, 2018	BUY	$60.0 - $85.67 $71,400 - $101,947	1,190 Added 148.75%	1,990 $166,000
Q1 2018 May 11, 2018	BUY	$52.72 - $67.25 $31,632 - $40,350	600 Added 300.0%	800 $49,000
Q4 2017 Jan 17, 2018	SELL	$58.2 - $72.76 $130,659 - $163,346	-2,245 Reduced 91.82%	200 $11,000
Q3 2017 Oct 17, 2017	BUY	$57.01 - $118.75 $139,389 - $290,343	2,445	2,445 $141,000

Others Institutions Holding ICPT

# of Institutions

Shares Held

1.04M

Call Options Held

30K

Put Options Held

5.9K

View Full List

About INTERCEPT PHARMACEUTICALS, INC.

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

More about ICPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Account